JCAHO Visit an ‘Opportunity’ to Improve Pain Management

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 8
Volume 10
Issue 8

WASHINGTON-With a Joint Commission on Accreditation of Healthcare Organizations (JCAHO) visit looming, nurses at George Washington University Hospital used the opportunity to implement a staff education program to improve pain assessment and management.

WASHINGTON—With a Joint Commission on Accreditation of Healthcare Organizations (JCAHO) visit looming, nurses at George Washington University Hospital used the opportunity to implement a staff education program to improve pain assessment and management.

Reporting at a poster session during the Oncology Nursing Society’s 26th Annual Congress, Pam Malloy, RN, MN, hospital education coordinator, described how her group prepared the nursing staff to meet JCAHO standards for pain management. Little money for extra classes and a short time frame made the task even more challenging.

The first task was to assess the nursing staff’s current level of knowledge by giving a pre-education pain management test (adapted from the postoperative pain study from the University of Wisconsin, Madison). The average score was 55%. Ms. Malloy’s group then developed a 2-day pain management class based on an analysis of the pre-education test results.

A patient education documentation form has been instrumental in facilitating communication among the multidisciplinary team members. Because understanding patients’ perceptions of their pain is the first step toward optimal pain assessment and management, the nursing staff is always looking for new pain assessment tools, Ms. Malloy said.

Current tools include a laminated card that nurses carry in their pocket for quick access when confronted with a patient experiencing pain. The pain scale ranges from 0 (no pain) to 5 (distressing pain) to 10 (unbearable pain). A graphic depiction of pain shows smiling faces, sad faces, and anguished faces; a numerical scale designates 0 as no hurt, 2 as hurts a little bit, and so on.

The education program has translated into action, Ms. Malloy reported. At baseline, 88% of nurses were documenting pain, and the percentage rose to 97% after education. Similarly, at baseline, 70% of RNs were using a numeric or descriptive pain scale, whereas 99% were doing so after education.

Ongoing pain education includes testing and educating new nurses during their orientation. Depending on the new nurse’s unit assignment, he or she may be required to take a pain assessment and management test.

Another important approach is the "bathroom blitz," in which small posters relating a single concept about pain are placed in staff bathrooms. These posters are changed monthly.

The nurse educators continually assess and reassess their educational outcomes. Unannounced chart audits, for example, provide a realistic look at whether a nurse is applying what he or she learned during pain management education. Deficiencies can be addressed—and re-teaching initiated—on the spot.

Finally, patients are educated about their right to appropriate pain assessment and management during their hospitalization. At discharge, patients and their families are given instruction in managing pain at home.

Recent Videos
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
Louis Potters, MD, FASTRO, FABS, FACR, describes how evidence-based radiation protocols may integrate with novel artificial intelligence software.
The use of enhanced imaging and adaptive radiotherapy has lessened the burden on patients with cancer receiving radiotherapy as treatment.
7 experts are featured in this series.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Related Content